Release
📈 Stocks
Eli Lilly Previews Oncology Pipeline Data for ESMO Congress Presentation
(just now)
Eli Lilly prepares to present key clinical trial updates for its investigational oncology candidates, including sofetabart mipitecan and olomorasib, at the upcoming…